Contact
Please use this form to send email to PR contact of this press release:
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
TO:
Please use this form to send email to PR contact of this press release:
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
TO: